ICU-Based Renal Replacement Therapy

1 Department of Intensive Care, Austin Hospital, Heidelberg, Melbourne, VIC, Australia. 2 Centre for Integrated Critical Care, School of Medicine, University of Melbourne, Melbourne, VIC, Australia. 3 Chair of Nephrology, Department of Medicine, University of Padova, Padua, Italy. 4 International Renal Research Institute of Vicenza (IRRIV), Vicenza, Italy. 5 Department of Nephrology, San Bortolo Hospital, Vicenza, Italy. 6 Department of Critical Care Medicine, Center for Critical Care Nephrology, University of Pittsburgh, Pittsburgh, PA. Dr. Bellomo has received grants and consultancy and speaking fees from BBraun and Baxter. Dr. Ronco has received consultancy and speaking fees from ASAHI, Astute, Biomerieux, B.Braun, Baxter, FMC, Toray, GE, OCD, Jafron, and Medtronic. Dr. Kellum has received grant support and/or consulting fees from AM Pharma, Astellas, Astute Medical, Atox Bio, Baxter, bioMerieux, NxStage, and Potrero. Dr. Kellum's institution received funding from Baxter, and he received funding from Baxter and NxStage. Dr. Baldwin has disclosed that he does not have any potential conflicts of interest. For information regarding this article, E-mail: [email protected]